Johnson & Johnson announced the suspension of clinical trials of its COVID-19 vaccine due to an unknown disease in one of the participants of the test.
In the final phase of clinical trials of the coronavirus vaccine, Johnson & Johnson suspended testing. The third stage was launched on September 23. As reported, more than 60 thousand people from different countries participated in it.
Today, the company announced the suspension of vaccine doses due to the condition of one of the subjects. Information about the health of this volunteer is being clarified and should be published later.
Photo: from open sources